REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
7.80
-0.10 (-1.27%)
At close: Jun 18, 2026, 4:00 PM EDT
7.92
+0.12 (1.54%)
After-hours: Jun 18, 2026, 7:45 PM EDT
REGENXBIO Market Cap
REGENXBIO has a market cap or net worth of $403.24 million as of June 18, 2026. Its market cap has decreased by -20.24% in one year.
Market Cap
403.24M
Enterprise Value
501.15M
1-Year Change
-20.24%
Ranking
Category
Stock Price
$7.80
Market Cap Chart
Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $403.24M, a decrease of -46.18%. That is a compound annual growth rate of -5.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 403.20M | -44.69% |
| Dec 31, 2025 | 729.00M | 90.34% |
| Dec 31, 2024 | 383.00M | -51.50% |
| Dec 29, 2023 | 789.70M | -19.57% |
| Dec 30, 2022 | 981.90M | -29.79% |
| Dec 31, 2021 | 1.40B | -17.57% |
| Dec 31, 2020 | 1.70B | 12.32% |
| Dec 31, 2019 | 1.51B | 0.48% |
| Dec 31, 2018 | 1.50B | 45.18% |
| Dec 29, 2017 | 1.04B | 110.87% |
| Dec 30, 2016 | 491.10M | 12.43% |
| Dec 31, 2015 | 436.80M | -41.71% |
| Sep 17, 2015 | 749.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ovid Therapeutics | 423.67M |
| Ocugen | 419.77M |
| Benitec Biopharma | 417.41M |
| Century Therapeutics | 413.01M |
| Editas Medicine | 412.81M |
| Sagimet Biosciences | 412.50M |
| Adlai Nortye | 404.00M |
| Autolus Therapeutics | 401.88M |